ATE264867T1 - Reduzierung von gelation von fettsäureacylierten proteinen unter nutzung von zitratpuffer - Google Patents

Reduzierung von gelation von fettsäureacylierten proteinen unter nutzung von zitratpuffer

Info

Publication number: ATE264867T1
Authority: AT; Austria
Prior art keywords: citrate buffer; processing; acylated proteins; fatty acylated; gelation
Prior art date: 1995-06-07

Application number

AT96303973T

Other languages

German (de)

English (en)

Inventor

Jeffrey Clayton Baker

Jose M Hanquier

Warren E Shrader

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-07

Filing date

1996-05-31

Publication date

2004-05-15

1996-05-31 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

2004-05-15 Application granted granted Critical

2004-05-15 Publication of ATE264867T1 publication Critical patent/ATE264867T1/de

Links

239000007979 citrate buffer Substances 0.000 title abstract 2
238000001879 gelation Methods 0.000 title abstract 2
108091005632 fatty acylated proteins Proteins 0.000 title 1
238000000034 method Methods 0.000 abstract 2
108090000623 proteins and genes Proteins 0.000 abstract 2
102000004169 proteins and genes Human genes 0.000 abstract 2
KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 abstract 1
101000976075 Homo sapiens Insulin Proteins 0.000 abstract 1
239000000872 buffer Substances 0.000 abstract 1
239000006172 buffering agent Substances 0.000 abstract 1
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Gastroenterology & Hepatology (AREA)
Endocrinology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Toxicology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Diabetes (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Fats And Perfumes (AREA)

AT96303973T 1995-06-07 1996-05-31 Reduzierung von gelation von fettsäureacylierten proteinen unter nutzung von zitratpuffer ATE264867T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/484,545 US5631347A (en)	1995-06-07	1995-06-07	Reducing gelation of a fatty acid-acylated protein

Publications (1)

Publication Number	Publication Date
ATE264867T1 true ATE264867T1 (de)	2004-05-15

Family

ID=23924602

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96303973T ATE264867T1 (de)	1995-06-07	1996-05-31	Reduzierung von gelation von fettsäureacylierten proteinen unter nutzung von zitratpuffer

Country Status (10)

Country	Link
US (1)	US5631347A (2)
EP (1)	EP0747390B1 (2)
JP (1)	JP3962430B2 (2)
AT (1)	ATE264867T1 (2)
AU (1)	AU5951596A (2)
CA (1)	CA2223531A1 (2)
DE (1)	DE69632224T2 (2)
DK (1)	DK0747390T3 (2)
ES (1)	ES2218569T3 (2)
WO (1)	WO1996040188A1 (2)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9316895D0 (en)	1993-08-13	1993-09-29	Guy S And St Thomas Hospitals	Hepatoselective insulin analogues
US6451970B1 (en) *	1996-02-21	2002-09-17	Novo Nordisk A/S	Peptide derivatives
US5948751A (en) *	1996-06-20	1999-09-07	Novo Nordisk A/S	X14-mannitol
US7658938B2 (en) *	1999-02-22	2010-02-09	Merrion Reasearch III Limited	Solid oral dosage form containing an enhancer
US8119159B2 (en) *	1999-02-22	2012-02-21	Merrion Research Iii Limited	Solid oral dosage form containing an enhancer
US7169889B1 (en)	1999-06-19	2007-01-30	Biocon Limited	Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
CN1406131A (zh) *	2000-12-25	2003-03-26	株式会社资生堂	活化交感神经的香料组合物
US7060675B2 (en) *	2001-02-15	2006-06-13	Nobex Corporation	Methods of treating diabetes mellitus
US6867183B2 (en) *	2001-02-15	2005-03-15	Nobex Corporation	Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6835802B2 (en) *	2001-06-04	2004-12-28	Nobex Corporation	Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US7713932B2 (en) *	2001-06-04	2010-05-11	Biocon Limited	Calcitonin drug-oligomer conjugates, and uses thereof
US6713452B2 (en) *	2001-06-04	2004-03-30	Nobex Corporation	Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6858580B2 (en) *	2001-06-04	2005-02-22	Nobex Corporation	Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en) *	2001-06-04	2004-12-07	Nobex Corporation	Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en)	2001-06-04	2004-12-07	Nobex Corporation	Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US20030119734A1 (en)	2001-06-28	2003-06-26	Flink James M.	Stable formulation of modified GLP-1
US7312192B2 (en) *	2001-09-07	2007-12-25	Biocon Limited	Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US6770625B2 (en)	2001-09-07	2004-08-03	Nobex Corporation	Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US6913903B2 (en) *	2001-09-07	2005-07-05	Nobex Corporation	Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en) *	2001-09-07	2007-03-27	Biocon Limited	Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7166571B2 (en) *	2001-09-07	2007-01-23	Biocon Limited	Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
EP1430082B1 (en) *	2001-09-07	2009-10-28	Biocon Limited	Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7030082B2 (en) *	2001-09-07	2006-04-18	Nobex Corporation	Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
AU2003236521A1 (en)	2002-06-13	2003-12-31	Nobex Corporation	Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
WO2004105790A1 (en)	2003-06-03	2004-12-09	Novo Nordisk A/S	Stabilized pharmaceutical peptide compositions
JP4936884B2 (ja)	2003-06-03	2012-05-23	ノボ・ノルデイスク・エー／エス	安定化された薬学的ペプチド組成物
PT1687019T (pt)	2003-11-20	2018-02-26	Novo Nordisk As	Formulações de péptidos que contêm polietileno glicol que são ótimas para produção e para utilização em dispositivos de injeção
CN103223160B (zh)	2004-07-19	2015-02-18	比奥孔有限公司	胰岛素-低聚物共轭物,制剂及其用途
EP1789434B1 (en)	2004-08-31	2013-11-20	Novo Nordisk A/S	Use of tris(hydroxymethyl) aminomethane for the stabilization of peptides, polypeptides and proteins
EP2494983B1 (en)	2004-11-12	2019-04-24	Novo Nordisk A/S	Stable formulations of glp-1
WO2007117706A2 (en) *	2006-04-07	2007-10-18	Merrion Research Iii Limited	Solid oral dosage form containing an enhancer
EP2040731A4 (en) *	2006-06-09	2010-05-19	Merrion Res Iii Ltd	SOLID DOSAGE FORM FOR ORAL ADMINISTRATION CONTAINING AN ACTIVATOR
US9241908B2 (en) *	2007-10-16	2016-01-26	Biocon Limited	Orally administrable solid pharmaceutical composition and a process thereof
CN102046192B (zh) *	2008-05-07	2014-11-19	默里昂研究Ⅲ有限公司	GnRH相关化合物的组合物及制备方法
WO2010099255A1 (en) *	2009-02-25	2010-09-02	Merrion Research Iii Limited	Composition and drug delivery of bisphosphonates
WO2011064316A2 (en)	2009-11-25	2011-06-03	Paolo Botti	Mucosal delivery of peptides
US20110182985A1 (en) *	2010-01-28	2011-07-28	Coughlan David C	Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
WO2011120033A1 (en) *	2010-03-26	2011-09-29	Merrion Research Iii Limited	Pharmaceutical compositions of selective factor xa inhibitors for oral administration
WO2012094598A2 (en)	2011-01-07	2012-07-12	Merrion Research Iii Limited	Pharmaceutical compositions of iron for oral administration
US9155775B1 (en)	2015-01-28	2015-10-13	Teva Pharmaceutical Industries, Ltd.	Process for manufacturing glatiramer acetate product
US10265384B2 (en)	2015-01-29	2019-04-23	Novo Nordisk A/S	Tablets comprising GLP-1 agonist and enteric coating
EP3585798A4 (en) *	2017-02-27	2020-10-14	Duke University	IN VIVO PROTEIN N ACYLATION
HUE066356T2 (hu)	2017-08-24	2024-07-28	Novo Nordisk As	GLP-1 készítmények és alkalmazásaik
PE20221575A1 (es)	2020-02-18	2022-10-06	Novo Nordisk As	Formulaciones farmaceuticas

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2626228A (en) *	1945-05-17	1953-01-20	Novo Terapeutisk Labor As	Method of producing crystalline insulin
FR1468831A (fr) *	1965-10-05	1967-02-10	Roussel Uclaf	Procédé de préparation de nouveaux composés polypeptidiques et produits en résultant
DE1902865A1 (de) *	1968-02-01	1969-09-11	American Home Prod	Substituierte Insulin-Derivate,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
US3591574A (en) *	1968-05-29	1971-07-06	American Home Prod	Tri-n-phenylglycyl derivatives of insulin
US3528960A (en) *	1968-10-07	1970-09-15	Lilly Co Eli	N-carboxyaroyl insulins
US3823125A (en) *	1969-10-14	1974-07-09	American Home Prod	N-aminoacyl-substituted insulins
US3752798A (en) *	1969-12-02	1973-08-14	G Amird	Tris-na1,nb1,nepsilonb29 - (3-x-3-oxo - 1-y-prop-1-en-1-yl)(ndelta-(4-z-6-r-pyrimidin - 2 - yl) ornithine b22)-insulins and their preparation
US3869437A (en) *	1970-05-08	1975-03-04	Nat Res Dev	Mono-, di, and N{HD A1{B , N{HU B1{B , N{HU B29{B -tri-acylated insulin
US3950517A (en) *	1970-05-08	1976-04-13	National Research Development Corporation	Insulin derivatives
GB1381273A (en) *	1971-01-28	1975-01-22	Nat Res Dev	Insulin derivatives
GB1381274A (en) *	1971-01-28	1975-01-22	Nat Res Dev	Insulin derivatives
US3864325A (en) *	1971-11-18	1975-02-04	Nat Res Dev	(N{HU Al{b , N{HU Bl{b , N{HU B29{B , carbamoyl)-(O{HU A14{B , O{HU B16{B , O{HU B26{B aryl) insulin derivatives
BE791949A (fr) *	1971-11-27	1973-05-28	Schering Ag	Derives d'insuline, leur preparation et leur utilisation
US3755569A (en) *	1972-07-25	1973-08-28	American Home Prod	Acyl substituted insulins
DE2252157C3 (de) *	1972-10-25	1976-03-18	Hoechst Ag	Zwischenprodukte zur herstellung von insulin, insulin-analogen und -derivaten und verfahren zur herstellung von insulin, insulin analogen und derivaten
NL7314766A (2) *	1972-10-31	1974-05-02
DE2253327A1 (de) *	1972-10-31	1974-05-09	Hoechst Ag	Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
US3878186A (en) *	1973-05-09	1975-04-15	Lilly Co Eli	Process for purifying insulin
US3876623A (en) *	1973-05-09	1975-04-08	Lilly Co Eli	Process for purifying insulin
US3903304A (en) *	1973-11-13	1975-09-02	Us Commerce	Acylated myofibrillar protein binder for aquacultural feeds and fish baits
DE2428412A1 (de) *	1974-06-12	1976-01-15	Hoechst Ag	Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
DE2439296A1 (de) *	1974-08-16	1976-02-26	Hoechst Ag	Verfahren zur herstellung von insulin, insulin-analogen und -derivaten
GB1492997A (en) *	1976-07-21	1977-11-23	Nat Res Dev	Insulin derivatives
US4430266A (en) *	1980-11-28	1984-02-07	Eli Lilly And Company	Process for producing an insulin precursor
US4654324A (en) *	1981-08-27	1987-03-31	Eli Lilly And Company	Human proinsulin pharmaceutical formulations
US4652548A (en) *	1981-08-27	1987-03-24	Eli Lilly And Company	Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin
US4486458A (en) *	1982-09-07	1984-12-04	A. E. Staley Manufacturing Company	Non-gelling corn steep liquor
US4569791A (en) *	1984-06-14	1986-02-11	Eli Lilly And Company	Anti-diabetic compounds
US4946828A (en) *	1985-03-12	1990-08-07	Novo Nordisk A/S	Novel insulin peptides
PH25772A (en) *	1985-08-30	1991-10-18	Novo Industri As	Insulin analogues, process for their preparation
US4764592A (en) *	1987-04-23	1988-08-16	Eli Lilly And Company	Crystalline human proinsulin and process for its production
JPH01254699A (ja) *	1988-04-05	1989-10-11	Kodama Kk	インスリン誘導体及びその用途
AU641631B2 (en) *	1988-12-23	1993-09-30	Novo Nordisk A/S	Human insulin analogues
US5514646A (en) *	1989-02-09	1996-05-07	Chance; Ronald E.	Insulin analogs modified at position 29 of the B chain
PT93057B (pt) *	1989-02-09	1995-12-29	Lilly Co Eli	Processo para a preparacao de analogos da insulina
US5130236A (en) *	1989-12-07	1992-07-14	Eli Lilly And Company	Process for producing des(64,65)-proinsulin
WO1992001476A1 (en) *	1990-07-26	1992-02-06	University Of Iowa Research Foundation	Novel drug delivery systems for proteins and peptides using albumin as a carrier molecule
US5304473A (en) *	1991-06-11	1994-04-19	Eli Lilly And Company	A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production
US5504188A (en) *	1994-06-16	1996-04-02	Eli Lilly And Company	Preparation of stable zinc insulin analog crystals
US5646242A (en) *	1994-11-17	1997-07-08	Eli Lilly And Company	Selective acylation of epsilon-amino groups
US5693609A (en) *	1994-11-17	1997-12-02	Eli Lilly And Company	Acylated insulin analogs

1995
- 1995-06-07 US US08/484,545 patent/US5631347A/en not_active Expired - Lifetime
1996
- 1996-05-31 AT AT96303973T patent/ATE264867T1/de not_active IP Right Cessation
- 1996-05-31 EP EP96303973A patent/EP0747390B1/en not_active Expired - Lifetime
- 1996-05-31 DE DE69632224T patent/DE69632224T2/de not_active Expired - Fee Related
- 1996-05-31 DK DK96303973T patent/DK0747390T3/da active
- 1996-05-31 ES ES96303973T patent/ES2218569T3/es not_active Expired - Lifetime
- 1996-06-04 WO PCT/US1996/007965 patent/WO1996040188A1/en not_active Ceased
- 1996-06-04 CA CA002223531A patent/CA2223531A1/en not_active Abandoned
- 1996-06-04 JP JP50083397A patent/JP3962430B2/ja not_active Expired - Fee Related
- 1996-06-04 AU AU59515/96A patent/AU5951596A/en not_active Abandoned

Also Published As

Publication number	Publication date
EP0747390A3 (en)	1997-06-04
EP0747390A2 (en)	1996-12-11
JPH11506739A (ja)	1999-06-15
WO1996040188A1 (en)	1996-12-19
DE69632224D1 (de)	2004-05-27
AU5951596A (en)	1996-12-30
ES2218569T3 (es)	2004-11-16
DK0747390T3 (da)	2004-07-26
JP3962430B2 (ja)	2007-08-22
EP0747390B1 (en)	2004-04-21
CA2223531A1 (en)	1996-12-19
DE69632224T2 (de)	2005-04-14
US5631347A (en)	1997-05-20

Legal Events

Date	Code	Title	Description
2004-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE69632224D1 (de)	2004-05-27	Reduzierung von Gelation von Fettsäureacylierten Proteinen unter Nutzung von Zitratpuffer
ATE388162T1 (de)	2008-03-15	Verfahren zur beseitigung von viren
HUP9900920A2 (hu)	1999-07-28	Eljárás emlőssejt-tenyészetekben termelt proteinek szializációjának szabályozására
NZ225032A (en)	1991-02-26	Method of extracting protein from microbial cells
DE3686654D1 (de)	1992-10-08	Verfahren zur isolierung rekombinanter polypeptide in biologisch aktiver form.
AU6687486A (en)	1987-06-18	Solubilization of protein aggregates
DK0378382T3 (da)	1997-06-16	Rekombinant DNA-fremgangsmåde og værtsceller
HUT68021A (en)	1995-04-04	Improved activating process of recombinant proteins
SE8801701D0 (sv)	1988-05-05	Production technology based on enzymic method
DK0839006T4 (da)	2010-12-06	Fremgangsmåde til stabilisering af proteiner i et surt miljø med et højester-pectin
AU3257197A (en)	1998-01-07	Process for the activation of denatured protein
MXPA02010643A (es)	2004-05-17	Un metodo de tratamiento de proteinas de soya y un producto de proteina de soya producido mediante este metodo.
ATE278781T1 (de)	2004-10-15	Tioredioxine h aus zwig und hart-weizen und ähnliche proteine, diese kodierende dna-fragmente und verfahren zu ihrer herstellung
KR927003623A (ko)	1992-12-18	변성단백질의 활성회복 방법
ATE261985T1 (de)	2004-04-15	Verfahren zur herstellung von richtig gefaltetem, biologisch aktivem, rekombinantem protein
AU651830B2 (en)	1994-08-04	In vitro processing of fusion proteins
NO2006006I1 (no)	2006-05-15	Aktivert protein C
AU590712B2 (en)	1989-11-16	Immune interferon and method for its purification
ATE311401T1 (de)	2005-12-15	Erhöhte ausbeuten eines kristallinen proteins durch verwendung eines festen adsorptionsmaterials
DE3880122D1 (de)	1993-05-13	Verfahren zur solubilisierung von unloeslichem protein.
Dodd	1990	THE HORMONAL CONTROL OF ALPHA-LACTALBUMIN AND BETA-LACTOGLOBULIN IN PIG MAMMARY GLAND.
Tani et al.	1996	Academy of Dental Materials
KR930013106A (ko)	1993-07-21	연어 성장 호르몬의 정제 방법
MY103305A (en)	1993-05-29	Productions of proteins in active forms